OGN
Organon & Co
Price:  
13.79 
USD
Volume:  
3,750,911.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

OGN EV/EBITDA

259.8%
Upside

As of 2026-11-06, the EV/EBITDA ratio of Organon & Co (OGN) is 5.83. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. OGN's latest enterprise value is 11,042.39 mil USD. OGN's TTM EBITDA according to its financial statements is 1,893.00 mil USD. Dividing these 2 quantities gives us the above OGN EV/EBITDA ratio.

Range Selected
Trailing P/E multiples 9.6x - 16.4x 12.4x
Forward P/E multiples 12.3x - 16.1x 14.2x
Fair Price 29.02 - 89.96 49.62
Upside 110.4% - 552.4% 259.8%
13.79 USD
Stock Price
49.62 USD
Fair Price

OGN EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2026-11-05 5.83
2026-11-04 5.84
2026-11-03 5.84
2026-11-02 5.84
2026-10-30 5.84
2026-10-29 5.84
2026-10-28 5.83
2026-10-27 5.83
2026-10-26 5.83
2026-10-23 5.83
2026-10-22 5.83
2026-10-21 5.83
2026-10-20 5.83
2026-10-19 5.83
2026-10-16 5.83
2026-10-15 5.83
2026-10-14 5.83
2026-10-13 5.83
2026-10-12 5.83
2026-10-09 5.84
2026-10-08 5.83
2026-10-07 5.83
2026-10-06 5.83
2026-10-05 5.82
2026-10-02 5.82
2026-10-01 5.82
2026-09-30 5.82
2026-09-29 5.83
2026-09-28 5.82
2026-09-25 5.82
2026-09-24 5.82
2026-09-23 5.82
2026-09-22 5.82
2026-09-21 5.82
2026-09-18 5.82
2026-09-17 5.82
2026-09-16 5.82
2026-09-15 5.82
2026-09-14 5.81
2026-09-11 5.81
2026-09-10 5.81
2026-09-09 5.82
2026-09-08 5.83
2026-09-04 5.83
2026-09-03 5.83
2026-09-02 5.83
2026-09-01 5.83
2026-08-31 5.83
2026-08-28 5.83
2026-08-27 5.83